Items where authors include "Cuomo, G."

Article

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Yan, Q., Bruni, C., Garaiman, A. et al. (25 more authors) (2025) Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database. Annals of the Rheumatic Diseases, 84 (4). pp. 620-631. ISSN 0003-4967

Bellando-Randone, S., Wilhalme, H., Bruni, C. et al. (15 more authors) (2025) The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort. Arthritis Research & Therapy, 27. 66. ISSN 1478-6354

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Colalillo, A., Pellicano, C., Ananyeva, L.P. et al. (12 more authors) (2023) Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care & Research. ISSN 2151-464X

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lescoat, A., Huscher, D., Schoof, N. et al. (204 more authors) (2023) Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. Rheumatology, 62 (6). pp. 2178-2188. ISSN 1462-0324

Hughes, M., Huang, S., Alegre-Sancho, J.J. et al. (98 more authors) (2023) Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology, 62 (SI). SI54-SI63. ISSN 1462-0324

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Conference or Workshop Item

Danzo, F., Gjeloshi, K., Abignano, G. et al. (4 more authors) (2020) P159 Current patient reported outcomes (PROs) poorly reflect changes in lung function in patients with systemic sclerosis. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow (Event Cancelled).

Danzo, F., Gjeloshi, K., Lettieri, G. et al. (6 more authors) (2020) Severity of hand vascular involvement as assessed by MRI Digital Artery Volume Index (DAVIX©) predicts worsening of clinical parameters and patient reported outcomes in scleroderma. In: British Society for Rheumatology Annual Conference 2020, (Conference was cancelled).

Proceedings Paper

Moschetti, L., Rovaris, S., Bonomi, F. et al. (35 more authors) (2025) OP0217 THE CLINICAL PHENOTYPE OF ANTI-Th/To+ PATIENTS IN SYSTEMIC SCLEROSIS: A CASE-CONTROL STUDY WITHIN THE EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) COHORT. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 181-182.

Moschetti, L., Pedretti, E., Bonomi, F. et al. (27 more authors) (2024) The Clinical Phenotype of Anti-Th/To plus Patients in Systemic Sclerosis: A Case-control Study Within the European Scleroderma Trials and Research (EUSTAR) Cohort. In: Arthritis & Rheumatology. ACR Convergence 2024, 14-19 Nov 2024, Washington D.C., USA. Wiley , pp. 4955-4958.

Lazzaroni, M.G., Wilson, M., Hensor, E. orcid.org/0000-0002-5245-4755 et al. (15 more authors) (2022) POS0893 Factors to consider for measuring the effect of lung function on patient reported outcomes in Systemic Sclerosis patients: Analysis of the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 743-744.

Gjeloshi, K., Danzo, F., Lettieri, G. et al. (6 more authors) (2020) O32 Digital artery volume index (DAVIX©) predicts the onset of future digital ulcers in patients with SSc. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , p. 15.

Gjeloshi, K., Danzo, F., Abignano, G. et al. (4 more authors) (2020) P150 Influence of patient reported arthritis activity in determining sHAQ, HAQ-DI and Cochin scores in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2020. Oxford University Press .